Nathan V. Lee
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Oncology top 5%
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
Papers in
- Oncology 14
- Cancer-related Molecular Pathways 6
- Peptidase Inhibition and Analysis 3
- Colorectal Cancer Treatments and Studies 2
-
- Liver physiology and pathology 3
- Co-authors
- M. Luisa Iruela‐ArispeBrion W. MurrayLily WuDeane F. MosherJoseph A. LooDouglas S. AnnisMakoto SatoTodd VanArsdale
- Journals
- Cancer Research (6 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (1 paper)Genomics (1 paper)Cancer Discovery (1 paper)
- Partner nations
- United StatesCanadaAustria
In The Last Decade
Nathan V. Lee
23 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Cancer Research 312
- Oncology 459
- Immunology and Allergy 75
- Pulmonary and Respiratory Medicine 326
- Molecular Biology 673
Countries citing papers authored by Nathan V. Lee
This map shows the geographic impact of Nathan V. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan V. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan V. Lee more than expected).
Fields of papers citing papers by Nathan V. Lee
This network shows the impact of papers produced by Nathan V. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan V. Lee. The network helps show where Nathan V. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan V. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2021 | 6 | |
| 3 | 2021 | 1 | |
| 4 | Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance Hit paper breakdown → | 2016 | 307 |
| 5 | 2015 | 116 | |
| 6 | 2015 | 27 | |
| 7 | 2014 | 3 | |
| 8 | 2014 | 3 | |
| 9 | 2013 | 31 | |
| 10 | 2013 | 34 | |
| 11 | 2013 | 29 | |
| 12 | 2012 | 77 | |
| 13 | 2012 | 53 | |
| 14 | 2012 | 40 | |
| 15 | 2011 | 32 | |
| 16 | 2011 | 17 | |
| 17 | 2010 | 1 | |
| 18 | 2008 | 195 | |
| 19 | 2006 | 169 | |
| 20 | 2005 | 85 |
About Nathan V. Lee
Nathan V. Lee is a scholar working on Oncology, Hepatology, Cancer Research, Cell Biology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Advanced Breast Cancer Therapies (4 papers), Cancer Mechanisms and Therapy (3 papers), Liver physiology and pathology (3 papers), Congenital heart defects research (3 papers), Peptidase Inhibition and Analysis (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Cancer Research (312 citations), Oncology (459 citations), Immunology and Allergy (75 citations), Pulmonary and Respiratory Medicine (326 citations) and Molecular Biology (673 citations). Nathan V. Lee has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include M. Luisa Iruela‐Arispe, Brion W. Murray, Lily Wu, Deane F. Mosher, Joseph A. Loo, Douglas S. Annis, Makoto Sato, Todd VanArsdale, Ping Chen and Rose Ann Ferre. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, Genomics and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.